Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of BKM120 as a Single Agent in First Line Therapy in Advanced, Metastatic, or Recurrent Endometrial Cancers

NCT01550380 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT01550380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01550380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of BKM120 as a Single Agent in First Line Therapy in Advanced, Metastatic, or Recurrent Endometrial Cancers
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Withdrawn
Start date
May 31, 2014
Completion date
July 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer